Search results
Found 12419 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Regent Lee
MBBS, MS(Vasc Surg), DPhil (Oxon), FRCS (Vasc Surg) Regent Lee - Professor of Interdisciplinary Innovations
Sarah Howles
DPhil, FRCS (Urol), MA (Cantab), PGCert Sarah Howles - Associate Professor of Urology and Wellcome Trust Clinical Career Development Fellow
Artjoms Portnojs
Artjoms Portnojs - Deputy Laboratory Manager (Islet Isolation Laboratory)
Ágata Carreira
PhD Ágata Carreira - Postdoctoral Researcher in RNA Translation and Anti-Cancer Immunity
Martin Gillies
MA, BM BCh, PhD, MRCS, AFHEA Martin Gillies - Senior Research Fellow and Lecturer
Richard Bryant
Richard Bryant - Associate Professor of Urology and Academic Director of NDS SITU
Paul Johnson
MA MD FRCS (Paed.Surg) FAAP Paul Johnson - Director of Oxford Islet Isolation and Islet Transplant Programmes and Professor of Paediatric Surgery
Keith Al-Hasani
BA (French) BSc (Hon) PhD Keith Al-Hasani - Senior Postdoctoral Scientist